US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.320
  • +0.110+9.09%
Trading Aug 26 15:34 ET
337.58MMarket Cap-3666P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptimmune Therapeutics Q2 2024 Earnings Date

Currency：USDAug 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
44.76M
128.23M
+83.47M
Beat Est.
+772.56%
+2399.63%
+186.47%
EPS
-0.03
0.24
+0.27
Beat Est.
+72.98%
+300.00%
+840.74%
Analyst Rating
Buy

Aug 26, 2024

Adaptimmune Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.155M--
--2024/Q3-- / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--
Mar 6, 20242023/Q4231.000K / 25.960M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.155M--
--2024/Q3-- / 20.489M--
Aug 12, 20242024/Q2128.231M / 44.762M--
May 15, 20242024/Q15.678M / 20.480M--
Mar 6, 20242023/Q4231.000K / 25.960M--

Unlock Free Earnings Estimates

Adaptimmune Therapeutics Earnings Reports

  • Adaptimmune Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 12 07:26 ET

  • Adaptimmune Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 22:23 ET

  • Adaptimmune Therapeutics | 10-K: FY2023 Annual Report

    Mar 6 07:18 ET

  • Adaptimmune Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 26, 2024

    Buy

    • Buy

      62.50%

    • Hold

      25.00%

    • Sell

      12.50%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg
    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.15%